Tatva Chintan Pharma Chem Limited (TATVA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 24.61B |
| Enterprise Value | 25.73B |
| P/E Ratio | 73.22 |
| PEG Ratio | 0.12 |
| Price/Sales Ratio | 6.77 |
| Price/Book Ratio | 4.81 |
| Enterprise/Revenue | 6.77 |
| Enterprise/EBITDA | 33.6 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.09 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 5.06B |
| Revenue/Share | 237.65 |
| Gross Profit | 1.82B |
| EBITDA | 967.07M |
| Net Income | 420.54M |
| Diluted EPS | 17.98 |
Balance Sheet
| Total Cash | 87.91M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 334.11 |
Price History
| 52-Week Change | 59.4 |
| 52-Week High | 1,838.1 |
| 52-Week Low | 981.5 |
| Moving Average 50 Days | 1,606.02 |
| Moving Average 200 Days | 1,332.11 |
Statistics
| Average Volume | 148,192 |
| Shares Outstanding | 23.39M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 0.12 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
